Literature DB >> 25036983

Immunobiology of radiotherapy: new paradigms.

Mansoor M Ahmed1, Chandan Guha, James W Hodge, Elizabeth Jaffee.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25036983      PMCID： PMC4275000          DOI： 10.1667/RR13849.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN： 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  13 in total

1.  Expression of arginase I in myeloid cells limits control of residual disease after radiation therapy of tumors in mice.

Authors:  Marka R Crittenden; Talicia Savage; Benjamin Cottam; Jason Baird; Paulo C Rodriguez; Pippa Newell; Kristina Young; Andrew M Jackson; Michael J Gough
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

Review 2.  The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation.

Authors:  Sandra Demaria; Karsten A Pilones; Claire Vanpouille-Box; Encouse B Golden; Silvia C Formenti
Journal:  Radiat Res       Date:  2014-06-17       Impact factor: 2.841

3.  An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.

Authors:  Yujo Kawashita; Niloy J Deb; Madhur K Garg; Rafi Kabarriti; Zuoheng Fan; Alan A Alfieri; Jayanta Roy-Chowdhury; Chandan Guha
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

Review 4.  Radiation as immunomodulator: implications for dendritic cell-based immunotherapy.

Authors:  Robert E Roses; Jashodeep Datta; Brian J Czerniecki
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

5.  The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling.

Authors:  Inge Verbrugge; Alessia Gasparini; Nicole M Haynes; Jim Hagekyriakou; Mara Galli; Trina J Stewart; Scott I Abrams; Hideo Yagita; Marcel Verheij; Ricky W Johnstone; Jannie Borst; Jacques Neefjes
Journal:  Radiat Res       Date:  2014-06-24       Impact factor: 2.841

Review 6.  Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy.

Authors:  Max M Wattenberg; Ahmed Fahim; Mansoor M Ahmed; James W Hodge
Journal:  Radiat Res       Date:  2014-06-24       Impact factor: 2.841

7.  In vivo effects of lattice radiation therapy on local and distant lung cancer: potential role of immunomodulation.

Authors:  Saravana Kanagavelu; Seema Gupta; Xiaodong Wu; Sakhi Philip; Max M Wattenberg; James W Hodge; Mariluz D Couto; Kristina D Chung; Mansoor M Ahmed
Journal:  Radiat Res       Date:  2014-07-18       Impact factor: 2.841

8.  Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.

Authors:  Molykutty J Aryankalayil; Adeola Y Makinde; Sofia R Gameiro; James W Hodge; Patricia P Rivera-Solis; Sanjeewani T Palayoor; Mansoor M Ahmed; C Norman Coleman
Journal:  Radiat Res       Date:  2014-07-08       Impact factor: 2.841

Review 9.  Considerations for combined immune checkpoint modulation and radiation treatment.

Authors:  Steven C Almo; Chandan Guha
Journal:  Radiat Res       Date:  2014-07-08       Impact factor: 2.841

10.  An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.

Authors:  Yujo Kawashita; Niloy J Deb; Madhur Garg; Rafi Kabarriti; Alan Alfieri; Masahiko Takahashi; Jayanta Roy-Chowdhury; Chandan Guha
Journal:  Radiat Res       Date:  2014-06-27       Impact factor: 2.841
View more
  19 in total

1.  Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.

Authors:  Chen Liao; Wei Xiao; Nuo Zhu; Zhiyuan Liu; Jiu Yang; Yanhu Wang; Mei Hong
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  The role of macrophage phenotype in regulating the response to radiation therapy.

Authors:  Xiaoshan Shi; Stephen L Shiao
Journal:  Transl Res       Date:  2017-11-20       Impact factor: 7.012

Review 3.  Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros.

Authors:  Kenneth B Ain
Journal:  Endocrine       Date:  2015-06-25       Impact factor: 3.633

Review 4.  Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Authors:  C Norman Coleman; Geoff S Higgins; J Martin Brown; Michael Baumann; David G Kirsch; Henning Willers; Pataje G S Prasanna; Mark W Dewhirst; Eric J Bernhard; Mansoor M Ahmed
Journal:  Clin Cancer Res       Date:  2016-05-06       Impact factor: 12.531

Review 5.  Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery.

Authors:  Mi-Sook Kim; Wonwoo Kim; In Hwan Park; Hee Jong Kim; Eunjin Lee; Jae-Hoon Jung; Lawrence Chinsoo Cho; Chang W Song
Journal:  Radiat Oncol J       Date:  2015-12-30

6.  Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.

Authors:  Sajjad Karim; Zeenat Mirza; Adeel G Chaudhary; Adel M Abuzenadah; Mamdooh Gari; Mohammed H Al-Qahtani
Journal:  Int J Mol Sci       Date:  2016-02-19       Impact factor: 5.923

Review 7.  Radiation-induced immune responses: mechanisms and therapeutic perspectives.

Authors:  Hoibin Jeong; Seoyeon Bok; Beom-Ju Hong; Hyung-Seok Choi; G-One Ahn
Journal:  Blood Res       Date:  2016-09-23

Review 8.  Developing immunotherapy strategies in the treatment of prostate cancer.

Authors:  James L Gulley; Ravi A Madan
Journal:  Asian J Urol       Date:  2016-08-30

9.  Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.

Authors:  Ercan Cacan; Alexander M Spring; Anita Kumari; Susanna F Greer; Charlie Garnett-Benson
Journal:  Int J Mol Sci       Date:  2015-12-21       Impact factor: 5.923

Review 10.  Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.

Authors:  Minghuan Li; Xiaoli Zhang; Fen Zhao; Yijun Luo; Li Kong; Jinming Yu
Journal:  Radiat Oncol       Date:  2016-02-05       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.